International Journal of Hematology and Oncology
2023, Vol 33, Num 4 Page(s): 128-133
THE RESULTS OF MALE BREAST CANCER PATIENTS TREATED WITH RADIOTHERAPY FOLLOWING MASTECTOMY
MUZAFFER BEDRİ ALTUNDAĞ1, SEMA DURMUŞ DÜZGÜN1, GÜLÇİN ERTAŞ1, ALİ RIZA ÜÇER1, TAMER ÇALIKOĞLU1, HAYATİ ABANUZ1, KENAN ÖZBAĞI1, ATİLA DEMİRKASIMOĞLU1, HAKAN BEKİR BAKKAL1, BEKTAŞ KAYA1
SB Ankara Onkoloji Hastanesi Radyasyon Onkolojisi Kliniği, ANKARA
Keywords: breast cancer, male, radiotherapy, chemotherapy
Twelve male breast cancer patients who were diagnosed and followed between January 1995 and July 2003 in the Department of Radiation Oncology at Ankara Oncology Hospital were retrospectively analyzed. All patients received radiotherapy following mastectomy. This patient population comprises 1.5 % of all 766 breast cancer patients treated with radiotherapy during the same period. Median age was 58 (range, 27-74). Of these 12 patients, 7 (58%) patients had modified radical mastectomy, 3 (25%) patients had simple mastectomy and 2 (17%) patients had radical mastectomy. According to TNM staging system, 1 patient had stage I disease, 1 patient had stage II A disease, 4 patients had stage IIB disease, 2 patients had stage IIIA disease and 4 patients had stage IIIB disease. While 10 patients received adjuvant systemic chemotherapy ( CMF-5 patients, CAF/CEF-5 patients), 8 patients received adjuvant hormonal treatment. Median follow-up was 39 months (range, 4-98) and all patients were alive with or without disease recurrence. Two patients showed local recurrences on the chest wall at 10th and 33rd months following radiotherapy. The one who developed local recurrence 10 months following radiotherapy also had bone metastasis at the same time. Bone metastasis were observed in 3 patients at 24th, 57th and 84th months following radiotherapy. Seven patients are still recurrence free.
MUZAFFER BEDRİ ALTUNDAĞ1, SEMA DURMUŞ DÜZGÜN1, GÜLÇİN ERTAŞ1, ALİ RIZA ÜÇER1, TAMER ÇALIKOĞLU1, HAYATİ ABANUZ1, KENAN ÖZBAĞI1, ATİLA DEMİRKASIMOĞLU1, HAKAN BEKİR BAKKAL1, BEKTAŞ KAYA1
SB Ankara Onkoloji Hastanesi Radyasyon Onkolojisi Kliniği, ANKARA
Keywords: breast cancer, male, radiotherapy, chemotherapy
Twelve male breast cancer patients who were diagnosed and followed between January 1995 and July 2003 in the Department of Radiation Oncology at Ankara Oncology Hospital were retrospectively analyzed. All patients received radiotherapy following mastectomy. This patient population comprises 1.5 % of all 766 breast cancer patients treated with radiotherapy during the same period. Median age was 58 (range, 27-74). Of these 12 patients, 7 (58%) patients had modified radical mastectomy, 3 (25%) patients had simple mastectomy and 2 (17%) patients had radical mastectomy. According to TNM staging system, 1 patient had stage I disease, 1 patient had stage II A disease, 4 patients had stage IIB disease, 2 patients had stage IIIA disease and 4 patients had stage IIIB disease. While 10 patients received adjuvant systemic chemotherapy ( CMF-5 patients, CAF/CEF-5 patients), 8 patients received adjuvant hormonal treatment. Median follow-up was 39 months (range, 4-98) and all patients were alive with or without disease recurrence. Two patients showed local recurrences on the chest wall at 10th and 33rd months following radiotherapy. The one who developed local recurrence 10 months following radiotherapy also had bone metastasis at the same time. Bone metastasis were observed in 3 patients at 24th, 57th and 84th months following radiotherapy. Seven patients are still recurrence free.